Life360, Inc. filings document regulatory disclosures for a Delaware technology company whose common stock trades on Nasdaq under LIF. Form 8-K reports furnish operating and financial results, Regulation FD presentation materials, material-event disclosures, material agreements, shareholder voting matters and capital-structure information.
Proxy materials describe board and executive compensation matters, equity awards, corporate governance and voting procedures. The filing record also reflects disclosure areas tied to Life360’s family safety platform, subscription metrics, advertising initiatives, legal and compliance oversight, and public-company securities reporting.
LIF filed to permit the sale of 27,000 shares of common stock, held at Fidelity Brokerage Services LLC, with an aggregate market value of $1,710,074.92, planned for August 4, 2026 on NASDAQ. The sale is linked to a stock option exercise for cash. Over the prior three months, Christopher Hulls reported additional common stock sales totaling 46,766 shares across three transactions on May 28, June 18, and July 16, 2026, for aggregate proceeds of $2,215,413.72.
Brittany B. Morin filed to sell common stock of LIF through Fidelity Brokerage Services LLC. The filing covers 10,701 shares of common stock listed on NASDAQ, with an aggregate market value of $642,060.00, for a proposed sale date of August 4, 2026.
The shares derive from multiple equity compensation events, including restricted stock vesting on dates such as June 9, 2021, September 8, 2022, December 8, 2022, June 8, 2023, December 8, 2023, and June 8, 2026, plus a stock option exercise on August 4, 2026 totaling 4,883 shares. During the prior three months, Morin sold 4,655 shares of common stock on June 29, 2026 for $256,025.00.
Paradice Investment Management Pty Ltd reported a beneficial ownership position in Life360, Inc. common stock. Paradice beneficially owns 4,320,665 shares, representing 5.33% of Life360’s common stock. Paradice has shared voting power over 178,085 shares and shared dispositive power over all 4,320,665 shares, with no sole voting or dispositive power reported.
Life360 director Chris Hulls exercised 27,000 stock options at an exercise price of $2.53 per share, receiving the same number of common shares, then sold 14,345 shares at a weighted average of $55.74 (range $55.46–$56.13) under a Rule 10b5-1 trading plan adopted on December 16, 2025. Following these transactions, he holds 1,242,386 shares directly (including CDIs and 134,496 RSUs), and three 2023 irrevocable family trusts each hold 195,312 shares indirectly.
A security holder named Christopher Hulls has filed a notice of proposed sale of 14,345 shares of common stock through Fidelity Brokerage Services LLC, to be sold for cash on or about 07/16/2026 on the NASDAQ, following a stock option exercise.
The filing also lists common‑stock sales during the past three months: 16,105 shares on 04/16/2026 for $732,962.71, 16,379 shares on 05/28/2026 for $660,686.27, and 16,042 shares on 06/18/2026 for $755,124.21.
Life360, Inc. director Charles J. Prober exercised stock options to acquire 7,930 shares of common stock at $11.18 per share, then sold 7,930 shares at $53.05 per share in an open-market transaction executed under a pre-established Rule 10b5-1 trading plan.
After these transactions, Prober holds 109,911 shares of common stock directly, plus 4,455 restricted stock units, and retains 31,720 fully vested, exercisable stock options that expire on April 12, 2028.
Charles Prober filed to sell common stock of issuer LIF through Fidelity Brokerage Services LLC. The planned sale involves 7,930 shares, with a stated value of 420,686.50, following a stock option exercise by the issuer on 07/13/2026. The shares are listed on NASDAQ and the sale is to be made for cash.
Life360, Inc. director John Philip Coghlan reported open-market sales of company common stock executed through a related trust. The John Coghlan Living Trust sold a total of 4,000 shares of Life360 common stock in two transactions on July 1, 2026, at weighted average prices of $56.04 and $56.57 per share, under a pre-arranged Rule 10b5-1 trading plan.
After these sales, the John Coghlan Living Trust held 24,431 shares of Life360 common stock. Related indirect holdings also include 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust, while direct holdings total 5,676 shares, including 4,840 restricted stock units that may convert into shares upon vesting.
Life360, Inc. ownership filing reports that Hyperion Asset Management Limited beneficially owned 3,254,444 shares of common stock, representing 4.06% of the class as of 06/30/2026. The filing states Hyperion has sole voting and dispositive power over those shares. The amendment is signed by Mark Arnold on 07/02/2026.
Life360, Inc. director Morin Brit sold 4,655 shares of common stock in an open-market sale at $55.00 per share on June 29, 2026. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026, which automatically executes trades based on preset criteria.
After this sale, Brit directly holds 25,975 shares of Life360 common stock. This total includes 4,636 restricted stock units (RSUs), each representing a contingent right to receive one share of common stock when the RSUs vest, reflecting ongoing stock-based compensation.